Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial
Helicobacter · 2026-09 · 31 (5)
DOI: 10.1111/hel.70171 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Helicobacter, online erschienen am 13.10.2026. Verfasst von Chitchai Rattananukrom und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Helicobacter Infections, Anti-Bacterial Agents, Atorvastatin, Helicobacter pylori. Die Arbeit nennt 27 Literaturangaben. Gefördert von: The Gastroenterological Association of Thailand, Khon Kaen University.
Abstract (Originalsprache)
Background and Aims Standard triple therapy (STT) for Helicobacter pylori ( H. pylori ) infection has become suboptimal. Atorvastatin may improve eradication rates by promoting autophagy and reducing inflammation. This study aimed to evaluate the efficacy and safety of adjuvant atorvastatin with STT compared to STT alone for H. pylori eradication.
Methods
In this randomized, placebo‐controlled trial, 138 treatment‐naïve patients with H. pylori infection were randomized to two groups. The intervention group ( n = 70) received a 14‐day regimen of omeprazole, amoxicillin, clarithromycin, and atorvastatin (40 mg once daily). The control group ( n = 68) received the same regimen with a matching placebo. The primary endpoint was H. pylori eradication, assessed by a urea breath test 4–6 weeks after treatment completion. Secondary endpoints included CYP2C19 and CYP3A4/5 genotypes, adverse events, and patient compliance.
Results
The eradication rate in the intervention group was significantly higher than in the control group in both the per‐protocol (97.1% vs. 85.3%) and intention‐to‐treat (ITT) analyses (95.7% vs. 85.3%). The absolute risk difference for the ITT analysis was 10.4% (95% CI, 0.75 to 20.1; p = 0.03). The distribution of CYP2C19 and CYP3A4/5 genotypes was similar between groups. No clinically significant differences in adverse events were observed.
Conclusion
Adjuvant therapy with atorvastatin combined with STT significantly improved H. pylori eradication rates without clinically significant adverse events. Further randomized controlled trials in diverse populations and with varying antibiotic resistance patterns are needed to better clarify the effects of statins on H. pylori treatment. Trial Registration Thai Clinical Trial Registry, No. TCTR20220201001
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Division of Critical Care, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Srinagarind Center of Excellence of Endoscopy, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
ORCID-Profile: Chitchai Rattananukrom, Anupol Panitchote, Suda Vannaprasaht, Tanita Suttichaimongkol, Wattana Sukeepaisarnjaroen, Pisaln Mairiang, Witsarut Manasirisuk
Förderung
- The Gastroenterological Association of Thailand
- Khon Kaen University
Zitieren
APA
Rattananukrom, C., Waranophirun, P., Panitchote, A., Vannaprasaht, S., Suttichaimongkol, T., Sawadpanich, K., Sangchan, A., Sukeepaisarnjaroen, W., Mairiang, P., & Manasirisuk, W. (2026). Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial. Helicobacter, 31(5). https://doi.org/10.1111/hel.70171
Vancouver
Rattananukrom C, Waranophirun P, Panitchote A, Vannaprasaht S, Suttichaimongkol T, Sawadpanich K, et al. Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial. Helicobacter. 2026;31(5). doi:10.1111/hel.70171
BibTeX
@article{Rattananukrom2026,
author = {Rattananukrom, Chitchai and Waranophirun, Punnaphol and Panitchote, Anupol and Vannaprasaht, Suda and Suttichaimongkol, Tanita and Sawadpanich, Kookwan and Sangchan, Apichart and Sukeepaisarnjaroen, Wattana and Mairiang, Pisaln and Manasirisuk, Witsarut},
title = {Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial},
journal = {Helicobacter},
year = {2026},
volume = {31},
number = {5},
doi = {10.1111/hel.70171}
}
EUVIMED